Complement Lysis Activity in Autologous Plasma Is Linked to Lower Viral Loads in Early HIV Infection
Author Information
Author(s): Michael Huber, Marek Fischer, Benjamin Misselwitz, Amapola Manrique, Herbert Kuster, Barbara Niederöst, Rainer Weber, Viktor von Wyl, Huldrych F. Günthard, Alexandra Trkola
Primary Institution: University Hospital Zürich, Zürich, Switzerland
Hypothesis
Does antibody-mediated complement lysis contribute to controlling viremia in HIV-1 infection?
Conclusion
Antibody-mediated complement lysis develops quickly and is effective early in HIV infection, potentially aiding in viremia control.
Supporting Evidence
- Plasma from acutely infected patients showed lower complement lysis activity compared to chronically infected patients.
- Complement lysis activity was inversely correlated with viral loads during acute infection.
- Antibody responses to HIV envelope proteins were positively correlated with complement lysis activity.
Takeaway
When people get HIV, their body makes special proteins that can help destroy the virus. This study found that these proteins work better when the virus is new.
Methodology
The study measured complement lysis activity in plasma from 25 acutely infected and 31 chronically infected patients using a novel real-time PCR-based assay.
Potential Biases
Potential biases may arise from the selection of patient samples and the variability in individual immune responses.
Limitations
The study does not fully characterize the antibodies involved in complement lysis and their specific roles in viremia control.
Participant Demographics
25 acutely infected and 31 chronically infected patients, with a control group of 11 healthy donors.
Statistical Information
P-Value
p=0.001
Confidence Interval
95%
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website